What's new in hematopathology 2025: myeloid neoplasms in the WHO 5th edition and ICC.

IF 3 Q3 PATHOLOGY

Journal of Pathology and Translational Medicine Pub Date : 2025-11-01 Epub Date: 2025-10-22 DOI:10.4132/jptm.2025.09.24

Barina Aqil

引用次数: 0

Abstract

The previous edition of the World Health Organization (WHO) classification of hematolymphoid neoplasms was published in 2008 and later revised in 2017. A new 5th edition of the WHO classification of hematolymphoid neoplasms was released in 2022. Additionally, the Clinical Advisory Committee developed the International Consensus Classification (ICC) of hematolymphoid tumors, which differs from the WHO classification in several key defining features as outlined below.

Abstract Image

查看原文本刊更多论文

血液病理学2025的新进展：WHO第5版和ICC中的髓系肿瘤。

世界卫生组织（世卫组织）的上一版血淋巴肿瘤分类于2008年发布，后来于2017年进行了修订。世卫组织第五版新血淋巴肿瘤分类于2022年发布。此外，临床咨询委员会制定了血淋巴肿瘤的国际共识分类（ICC），该分类与世卫组织的分类在以下几个关键定义特征上有所不同。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Pathology and Translational Medicine PATHOLOGY-

CiteScore

5.00

自引率

4.20%

发文量

审稿时长

14 weeks

期刊介绍： The Journal of Pathology and Translational Medicine is an open venue for the rapid publication of major achievements in various fields of pathology, cytopathology, and biomedical and translational research. The Journal aims to share new insights into the molecular and cellular mechanisms of human diseases and to report major advances in both experimental and clinical medicine, with a particular emphasis on translational research. The investigations of human cells and tissues using high-dimensional biology techniques such as genomics and proteomics will be given a high priority. Articles on stem cell biology are also welcome. The categories of manuscript include original articles, review and perspective articles, case studies, brief case reports, and letters to the editor.